These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8152287

  • 1. Long-term persistence of AZT-resistance mutations in the plasma HIV-1 of patients removed from AZT therapy.
    Smith MS, Koerber KL, Pagano JS.
    Leukemia; 1994 Apr; 8 Suppl 1():S179-82. PubMed ID: 8152287
    [Abstract] [Full Text] [Related]

  • 2. Long-term persistence of zidovudine resistance mutations in plasma isolates of human immunodeficiency virus type 1 of dideoxyinosine-treated patients removed from zidovudine therapy.
    Smith MS, Koerber KL, Pagano JS.
    J Infect Dis; 1994 Jan; 169(1):184-8. PubMed ID: 7506280
    [Abstract] [Full Text] [Related]

  • 3. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
    Chow YK, Hirsch MS, Merrill DP, Bechtel LJ, Eron JJ, Kaplan JC, D'Aquila RT.
    Nature; 1993 Feb 18; 361(6413):650-4. PubMed ID: 7679778
    [Abstract] [Full Text] [Related]

  • 4. pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo.
    Eron JJ, Chow YK, Caliendo AM, Videler J, Devore KM, Cooley TP, Liebman HA, Kaplan JC, Hirsch MS, D'Aquila RT.
    Antimicrob Agents Chemother; 1993 Jul 18; 37(7):1480-7. PubMed ID: 7689822
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro study of resistance-associated genotypic mutations to nucleoside analogs.
    Gashnikova N, Plyasunova O, Kiseleva Y, Fedyuk N, Pokrovsky A.
    Nucleosides Nucleotides Nucleic Acids; 2003 Jul 18; 22(5-8):991-4. PubMed ID: 14565328
    [Abstract] [Full Text] [Related]

  • 7. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase.
    St Clair MH, Martin JL, Tudor-Williams G, Bach MC, Vavro CL, King DM, Kellam P, Kemp SD, Larder BA.
    Science; 1991 Sep 27; 253(5027):1557-9. PubMed ID: 1716788
    [Abstract] [Full Text] [Related]

  • 8. Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.
    Izopet J, Bicart-See A, Pasquier C, Sandres K, Bonnet E, Marchou B, Puel J, Massip P.
    J Med Virol; 1999 Dec 27; 59(4):507-11. PubMed ID: 10534734
    [Abstract] [Full Text] [Related]

  • 9. [Resistance of human immunodeficiency virus (HIV) to zidovudine. Genotypic analysis in strains isolated from Chilean patients].
    Vial PA, Vial C, Abarca K, Noriega M, Jiménez G, Labarca J, Gasep J, Palacios O, Pérez C, Acuña G.
    Rev Med Chil; 1998 Jan 27; 126(1):17-26. PubMed ID: 9629750
    [Abstract] [Full Text] [Related]

  • 10. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro.
    Larder BA, Kellam P, Kemp SD.
    Nature; 1993 Sep 30; 365(6445):451-3. PubMed ID: 7692302
    [Abstract] [Full Text] [Related]

  • 11. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
    Larder BA, Kemp SD.
    Science; 1989 Dec 01; 246(4934):1155-8. PubMed ID: 2479983
    [Abstract] [Full Text] [Related]

  • 12. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients.
    Mohri H, Singh MK, Ching WT, Ho DD.
    Proc Natl Acad Sci U S A; 1993 Jan 01; 90(1):25-9. PubMed ID: 7678340
    [Abstract] [Full Text] [Related]

  • 13. Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.
    Gu Z, Gao Q, Li X, Parniak MA, Wainberg MA.
    J Virol; 1992 Dec 01; 66(12):7128-35. PubMed ID: 1279198
    [Abstract] [Full Text] [Related]

  • 14. Natural resistance of human immunodeficiency virus type 2 to zidovudine.
    Reid P, MacInnes H, Cong ME, Heneine W, García-Lerma JG.
    Virology; 2005 Jun 05; 336(2):251-64. PubMed ID: 15892966
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of primary resistance to zidovudine and lamivudine in drug-naive human immunodeficiency virus type-1 infected patients: high proportion of reverse transcriptase codon 215 mutant in circulating lymphocytes and free virus.
    Trabaud MA, Leriche-Guerin K, Regis C, Bordes I, Cotte L, Detmer J, Kolberg J, Ritter J, Trépo C.
    J Med Virol; 2000 Jul 05; 61(3):352-9. PubMed ID: 10861645
    [Abstract] [Full Text] [Related]

  • 16. Zidovudine-resistant human immunodeficiency virus type 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells.
    Smith MS, Koerber KL, Pagano JS.
    J Infect Dis; 1993 Feb 05; 167(2):445-8. PubMed ID: 7678429
    [Abstract] [Full Text] [Related]

  • 17. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
    Boyer PL, Imamichi T, Sarafianos SG, Arnold E, Hughes SH.
    J Virol; 2004 Sep 05; 78(18):9987-97. PubMed ID: 15331732
    [Abstract] [Full Text] [Related]

  • 18. Thymidine-analog and multi-nucleoside resistance mutations are observed in both zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens.
    Ross L, Henry K, Paar D, Salvato P, Shaefer M, Fisher R, Liao Q, St Clair M.
    J Hum Virol; 2001 Sep 05; 4(4):217-22. PubMed ID: 11694850
    [Abstract] [Full Text] [Related]

  • 19. In vivo comparison of zidovudine resistance mutations in blood and CSF of HIV-1-infected patients.
    Wildemann B, Haas J, Ehrhart K, Wagner H, Lynen N, Storch-Hagenlocher B.
    Neurology; 1993 Dec 05; 43(12):2659-63. PubMed ID: 7504798
    [Abstract] [Full Text] [Related]

  • 20. Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected people.
    Rusconi S, De Pasquale MP, Mainini F, Bulgheroni E, Kurtagic S, Gori A, Violin M, Zanchetta N, Moroni M, Balotta C, Galli M.
    Antivir Ther; 1996 Dec 05; 1(4):211-9. PubMed ID: 11324823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.